|
CVRF
|
Group
|
Baseline
|
Week 4
|
Week 24
|
Change Baseline/Week 24
|
P Value
|
Partial eta2
|
|---|
|
BMI (kg/m2)
|
Bath 1
|
29.9 (5.3)
|
29.5 (5.0)
|
29.3 (4.9)
|
−0.6 (3.2)
| | |
|
Bath 2
|
27.4 (5.3)
|
27.5 (5.5)
|
27.2 (5.8)
|
−0.2 (3.5)
|
0.30
|
0.04
|
|
Control
|
31.3 (5.9)
|
31.5 (5.9)
|
31.1 (5.7)
|
−0.2 (3.7)
| | |
|
Waist circumference (cm)
|
Bath 1
|
105.5 (13.6)
|
103.7 (13.8)
|
104.1 (12.8)
|
−1.4 (8.4)
| | |
|
Bath 2
|
98.4 (12.7)
|
98.9 (14.6)
|
98.2 (15.6)
|
−0.2 (9.4)
|
0.69
|
0.01
|
|
Control
|
102.5 (10.7)
|
102.3 (9.9)
|
101.8 (10.7)
|
−0.7 (6.8)
| | |
|
Cholesterol total (mg/dl) (50–200)
|
Bath 1
|
219.4 (38.2)
|
215.2 (32.3)
|
211.1 (34.6)
|
−8.3 (23.3)
| | |
|
Bath 2
|
230.2 (35.0)
|
233.1 (32.4)
|
236.6 (47.3)
|
6.4 (28.5)
|
0.09
|
0.09
|
|
Control
|
226.9 (35.6)
|
212.9 (33.3)
|
222.2 (34.4)
|
−4.7 (22.2)
| | |
|
LDL (mg/dl) (<160)
|
Bath 1
|
134.5 (33.3)
|
135.7 (29.1)
|
129.9 (27.0)
|
−4.6 (20.0)
| | |
|
Bath 2
|
143.0 (30.6)
|
144.9 (25.7)
|
147.2 (32.7)
|
4.2 (20.1)
|
0.13
|
0.09
|
|
Control
|
136.8 (35.1)
|
128.9 (34.2)
|
141.7 (34.3)
|
4.9 (22.0)
| | |
|
HDL (mg/dl) (>40)
|
Bath 1
|
47.3 (13.1)
|
47.0 (15.3)
|
45.8 (11.0)
|
−1.5 (7.9)
| | |
|
Bath 2
|
51.4 (14.7)
|
52.8 (14.2)
|
51.1 (15.1)
|
−0.3 (9.4)
|
0.84
|
0.01
|
|
Control
|
44.0 (15.2)
|
45.8 (13.6)
|
45.9 (15.5)
|
1.9 (9.7)
| | |
|
LDL/HDL Quotient (<3)
|
Bath 1
|
2.9 (0.9)
|
3.1 (1.0)
|
3.0 (0.9)
|
0.1 (0.6)
| | |
|
Bath 2
|
3.1 (1.5)
|
2.9 (0.9)
|
3.0 (1.0)
|
−0.1 (0.9)
|
0.39
|
0.04
|
|
Control
|
3.5 (1.5)
|
3.1 (1.4)
|
3.6 (1.9)
|
0.1 (1.1)
| | |
|
Triglyceride (mg/dl) (<150)
|
Bath 1
|
168.0 (107.0)
|
146.0 (77.0)
|
126.0 (42.0)
|
−42.0 (77.6)
| | |
|
Bath 2
|
126.0 (56.0)
|
134.0 (66.0)
|
121.0 (56.0)
|
−5.0 (35.4)
|
0.77
|
0.01
|
|
Control
|
168.0 (95.0)
|
149.0 (68.0)
|
144.0 (57.0)
|
−24.0 (60.1)
| | |
|
CRP (mg/l) (0–5)
|
Bath 1
|
2.5 (2.3)
|
1.6 (1.3)
|
1.6 (1.3)
|
−0.9 (1.5)
| | |
|
Bath 2
|
2.3 (2.3)
|
1.8 (1.9)
|
2.3 (2.7)
|
0.0 (1.6)
|
0.64
|
0.02
|
|
Control
|
3.3 (2.3)
|
2.5 (2.3)
|
2.4 (2.5)
|
−0.9 (1.5)
| | |
|
Fasting blood glucose (mg/dl) (70–110)
|
Bath 1
|
110.0 (30.0)
|
101.0 (24.0)
|
104.0 (26.0)
|
−6.0 (18.1)
| | |
|
Bath 2
|
90.0 (18.0)
|
91.0 (12.0)
|
88.0 (8.0)
|
−2.0 (12.6)
|
0.55
|
0.03
|
|
Control
|
95.0 (15.0)
|
90.0 (15.0)
|
93.0 (15.0)
|
−2.0 (9.5)
| | |
- Analysis of covariance (ANCOVA) with baseline values as covariates. P-value and partial eta2 refer to time × group interaction
-
BMI body mass index, CRP C-reactive protein, HDL high-density lipoprotein, ITW immersion in thermoneutral water, LDL low-density lipoprotein
